New Study: Diabetes Raises Cancer Risk, Particularly Liver and Pancreatic Cancers. Does Diabetic Retinopathy Play a Role?
Alarming new research suggests diabetes increases cancer risk, especially for the liver and pancreas. The study explores a potential link between diabetic retinopathy (eye disease) and cancer development. Learn more about the connection and how to manage your health.
DR T S DIDWAL MD
6/1/20245 min read
The intersection of diabetes and cancer risk has been the subject of extensive research, with new findings continually emerging to enhance our understanding of how these conditions interplay. This analysis delves into the intricate relationship between diabetes, diabetic retinopathy (DR), and subsequent cancer risk, drawing insights from a comprehensive 12-year study. The study in BMC Medicine reveals that patients with diabetes have a notably higher mean annual incidence of cancer compared to those without diabetes. Specifically, the incidence rate stands at 1309.74 per 100,000 person-years for diabetic patients versus 1130.13 per 100,000 person-years for non-diabetic individuals, yielding an incidence ratio of 1.17. This elevated risk persists across various types of cancers, underscoring the broad impact diabetes can have on cancer susceptibility.
Key Points
Increased Cancer Risk in Diabetes: Individuals with diabetes have a significantly higher risk of developing various cancers compared to those without diabetes. The study reveals a 20% increased risk for overall cancer incidence and even higher risks for specific cancers like liver, pancreatic, oral, and colon cancers.
Diabetic Retinopathy Further Elevates Cancer Risk: The study demonstrates that diabetic patients with DR have an even greater chance of developing cancer compared to diabetic patients without DR. This risk goes up to 32% for total cancer incidence.
DR Stages and Cancer Risk: The analysis explores the connection between different DR stages and cancer risk. Patients with proliferative DR (PDR), a more advanced stage, exhibit a higher cancer incidence than those with non-proliferative DR (NPDR).
Detailed Cancer Risk Variations: The study breaks down the increased cancer risk by specific cancer types. It highlights a substantial rise in risk for cancers like liver (69%), pancreas (87%), and kidney (44%) in diabetic patients. Interestingly, diabetes seems to be associated with a lower risk for esophageal cancer.
Potential Shared Mechanisms: The research suggests potential explanations for the link between diabetes, DR, and cancer. It points towards shared factors like elevated levels of specific growth factors (VEGF and Ang-2) involved in both blood vessel growth (DR) and tumor growth (cancer).
Chronic Inflammation as a Contributor: The analysis emphasizes the role of chronic inflammation in both diabetes and cancer. It proposes that the persistent low-grade inflammation in DR, with the release of inflammatory mediators, might contribute to cancer development.
Hyperlipidemia and Cancer Risk: The study observed an interesting inverse association between hyperlipidemia (high cholesterol) and all-site cancer risk (except breast cancer) in diabetic patients. This might be due to metabolic factors or competing health risks.
The study reveals that patients with diabetes have a notably higher mean annual incidence of cancer compared to those without diabetes. Specifically, the incidence rate stands at 1309.74 per 100,000 person-years for diabetic patients versus 1130.13 per 100,000 person-years for non-diabetic individuals, yielding an incidence ratio of 1.17. This elevated risk persists across various types of cancers, underscoring the broad impact diabetes can have on cancer susceptibility.
Key Findings of the Study
Increased Cancer Risk in Diabetes: The study found that individuals with diabetes had a 20% higher risk of developing any type of cancer compared to those without diabetes.
Specific Cancers Most Affected: The risk was particularly high for liver, pancreatic, oral, colon, gallbladder, female reproductive organs, kidney, and brain cancers.
Diabetic Retinopathy and Cancer Risk: The study importantly revealed that patients with DR had an even greater risk of developing cancer compared to those without DR. This risk was 32% higher for total cancer incidence.
Stages of DR and Cancer Risk: The study further explored the different stages of DR and found that patients with proliferative DR (PDR), a more advanced stage, had a 13% higher risk of cancer compared to those with non-proliferative DR (NPDR).
Detailed Findings on Cancer Types
The multivariate survival analysis further delineates this relationship, highlighting that diabetic patients face a 20% higher risk of developing cancer compared to non-diabetic individuals. The risk is particularly pronounced for certain cancer types:
Liver Cancer: Diabetic patients have a 69% higher risk.
Pancreatic cancer: the risk is 87% higher.
Oral Cavity and Pharynx Cancer: There is a 30% increase in risk.
Colon cancer: A 25% increased risk is noted.
Gallbladder Cancer: The risk rises by 34%.
Female Genital Organ Cancer: There is a 30% higher risk.
Kidney cancer: The risk is elevated by 44%.
Brain and CNS Cancers: The risk increases by 31%.
Conversely, diabetes appears to confer a lower risk for esophageal cancer, with a hazard ratio of 0.83.
Impact of Diabetic Retinopathy (DR)
When considering diabetic retinopathy, the study finds that diabetes patients with DR have an even higher cancer risk than those without DR. The mean annual incidence of cancer in diabetes patients with DR is 1494.33 per 100,000 person-years, compared to 1151.51 per 100,000 person-years in those without DR, resulting in an incidence ratio of 1.32.
Cancer Risk Across DR Stages
Within the diabetic retinopathy cohort, those with proliferative diabetic retinopathy (PDR) exhibit a higher cancer incidence than those with non-proliferative diabetic retinopathy (NPDR). The mean annual incidence rates are 1464.64 per 100,000 person-years for PDR patients and 1329.56 per 100,000 person-years for NPDR patients. PDR patients specifically show increased risks for stomach, liver, female genital, and urinary tract cancers, and a borderline increase in colon cancer risk.
Hyperlipidemia and Cancer
Interestingly, the study observes a lower incidence of all-site cancer in patients with hyperlipidemia, except for female breast cancer. This inverse relationship may be due to metabolic effects or competing risks, where high cholesterol levels might lead to earlier cardiovascular mortality, thus reducing the likelihood of a cancer diagnosis.
Understanding the Link Between Diabetes and Cancer
While the exact reasons behind the increased cancer risk in diabetes remain unclear, the study suggests some potential connections:
Chronic Inflammation: Both diabetes and cancer are associated with chronic inflammation, a condition where the body's immune system is constantly activated. This inflammation can damage cells and contribute to cancer development.
Growth Factors: The study highlights the role of specific growth factors like VEGF and Ang-2, which are involved in both blood vessel growth (angiogenesis) in DR and tumor growth in cancer.
Pericyte Loss: Pericytes are cells that support blood vessels. The study suggests a link between pericyte loss in DR and similar processes involved in cancer metastasis.
Breakdown of Blood-Retinal Barrier: DR involves the breakdown of the blood-retinal barrier, which may allow inflammatory mediators to further contribute to cancer development.
Implications of the Study
This research highlights the importance of managing diabetes effectively to potentially reduce the risk of cancer. Maintaining good blood sugar control and receiving regular screenings for both diabetes and cancer are crucial. Additionally, the study's findings on DR suggest that managing and monitoring diabetic retinopathy may be another potential avenue for reducing cancer risk in diabetic patients.
Limitations and Future Research
While the study offers valuable insights, it is important to acknowledge some limitations. The research is observational, meaning it cannot definitively prove that diabetes causes cancer. Additionally, the study relied on claims data, which may not capture all relevant information. Further research is needed to explore the biological mechanisms linking diabetes, DR, and cancer development.
Conclusion
This study provides compelling evidence for a heightened risk of cancer in individuals with diabetes. It also sheds light on the potential role of DR in this association. By focusing on diabetes management, DR control, and further research into the underlying biological connections, healthcare professionals can work towards better strategies for preventing and treating both diabetes and cancer.
Journal Reference
Chang, WC., Hsieh, TC., Hsu, WL. et al. Diabetes and further risk of cancer: a nationwide population-based study. BMC Med 22, 214 (2024). https://doi.org/10.1186/s12916-024-03430-y
Related
Disclaimer
The information on this website is for educational and informational purposes only, and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition or treatment, and before undertaking a new healthcare regimen, and never disregard professional medical advice or delay in seeking it because of something you have read on this website.